Expression of somatostatin receptors in inflammatory lesions and diagnostic value of somatostatin receptor scintigraphy in patients with ANCA-associated small vessel vasculitis

Rheumatology

Volumn 43, Issue 2, 2004, Pages 195-201

  Neumann, Irmgard ^a   Mirszaei, S ^a   Birck, R ^b   Osinger, K ^a   Waldherr, R ^c   Kohn H D ^a   Meisl, F T ^a  

^a Wilhelminenspital ^*  (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Institute of Pathology   (Germany)

Author keywords

ANCA; Disease activity; ENT; Immunohistochemistry; Lymphocytes; Pulmonary; Radiology; Scintigraphy; Somatostatin receptor; Vasculitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; LAXATIVE; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR; TRACER;

ADULT; AGED; ARTICLE; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; EAR NOSE THROAT DISEASE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; LOWER RESPIRATORY TRACT; LUNG DISEASE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SMALL VESSEL VASCULITIS; UPPER RESPIRATORY TRACT; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; OTORHINOLARYNGOLOGIC DISEASES; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 1242297057     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg479     Document Type: Article

References (35)

1. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1982;98:76-85.
2. Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991;15: 315-33.
3. Primack SL, Müller NL. Radiologic manifestations of the systemic autoimmune diseases. Clin Chest Med 1998;19:573-86.
4. Hagen EC, Daha MR, Hermans J et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53:754-61.
5. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of anti neutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener's granulomatosis. A review and a meta-analysis. Ann Intern Med 1995;123:925-32.
6. Harper L, Savage COS. Pathogenesis of ANCA-associated vasculitis. J Pathol 2000;190:349-59.
7. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity. Arthritis Rheum 1992;35:1088-96.
8. Gephardt GN, Ahmad M, Tubbs RR. Pulmonary vasculitis (Wegener's granulomatosis) immunohistochemical study of T and B cell markers. Am J Med 1983;74:700-4.
9. Rasmussen N, Petersen J. Cellular immune responses and pathogenesis in c-ANCA positive vasculitides. J Autoimmun 1993;6:227-36.
10. Cunningham MA, Huang XR, Dowling JP, Tipping PG, Holdsworth SR. Prominence of cell-mediated immunity effectors in 'pauci-immune' glomerulonephritis. J Am Soc Nephrol 1999;10:499-506.
11. Ferrario F, Rastaldi MP. Necrotizing-crescentic glomerulonephritis in ANCA-associated vasculitis: the role of monocytes. Nephrol Dial Transpl 1999;14:1627-31.
12. Csernok E, Trabandt A, Müller A et al. Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999;42:742-50.
13. Bhathena S, Louie J, Schechter GP, Redman RS, Recant L. Identification of human mononuclear leucocytes bearing receptors for somatostatin and glucagon. Diabetes 1981;30:127-31.
14. Hiruma K, Koike T, Nakamura H et al. Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology 1990;71:480-5.
15. Kwekkeboom DJ, Krenning EP, Lamberts SW. The role of octreotide scintigraphy in clinical diagnosis and therapy. In: Scarpignato C, ed. Octreotide: From basic science to clinical medicine. Progress in basic and clinical pharmacology. Basel: S. Karger Ag, 1996:281-94.
16. Patel YC, Srikant CB. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hSSTR 1-5). Endocrinology 1994;135:2814-7.
17. Vanhagen PM, Krenning EP, Reubi JC et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 1994;21: 497-502.
18. Kwekkeboom DJ, Krenning EP, Kho GS, Breeman WAP, Van Hagen PM. Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med 1998;25:1284-92.
19. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides: The proposal of an international consensus conference. Arthritis Rheum 1994;37:1-87-92.
20. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87:671-8
21. Kazerooni EA, Lim FT, Mikhail A, Martinez FJ. Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology 1996;198:371-5.
22. Tsusumi A, Takano H, Ichikawa K, Kobayashi S, Koike T. Expression of somatostatin receptor subtype 2 mRNA in human lymphoid cells. Cell Immunol 1997;181:44-9.
23. Talme T, Ivanoff J, Hägglund R. Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3. Clin Exp Immunol 2001;125:71-9.
24. ten Bokum AM, Melief A, van der Ham F et al. Immunhistochemical localization of somatostatin receptor SST2A in human rheumatoid synovium. J Rheumatol 1999;256:532-5.
25. Jonker ND, Peters AM, Gaskin G, Pusey CD, Lavender JP. A retrospective study of radiolabeled granulocyte kinetics in patients with systemic vasculitis. J Nucl Med 1992;33:491-7.
26. Reuter H, Wraight EP, Qasim FJ, Lockwood CM. Managemant of systemic vasculitis: contribution of scintigraphic imaging to evaluation of disease activity and classification. Q J Med 1995;88:509-16.
27. Murphy JM, Balan KK, Toms A, Gomez-Anson B, Lockwood M. Radiolabeled leukocyte imaging in diffuse granulomatous involvement of the meninges in Wegener's granulomatosis: Scintigraphic findings and their role in monitoring treatment response to specific immunotherapy (humanized monoclonal antilymphocyte antibodies). Am J Neuroradiol 2000;21:1460-5.
28. Chisholm PM, Danpure HJ, Healey G, Osman S. Cell damage resulting from the labelling of rat lymphocytes and Hela S3 cells with In-oxine. J Nucl Med 1979;20:1308-11.
29. Blockmans DE, Maes A, Stroobants S, Bobbaers H, Mortelmans L. FDG-PET scan investigations in vasculitis, other than giant cell arteritis or polymyalgia rheumatica. Ann Rheum Dis 2001;60(Suppl. 1):56.
30. Blockmans D, Baeyens H, Van Loon R, Lauwers G, Bobbaers H. Periaortitis and aortic dissection due to Wegener's granulomatosis. Clin Rheumatol 2000;19:161-4.
31. Jamar F, Houssiau FA, Devogelaer JP et al. Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology 2002;41:53-61.
32. 18F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001;32:191-6.
33. Oyen WJG, Boerman OC, Claessens RA et al. Is somatostatin receptor scintigraphy suited to detection of acute infectious disease? Nucl Med Commun 1994;15:289-93.
34. Vanhagen PM, Markusse HM, Lamberts DJ, Kwekkeboom DJ, Reubi JC, Krenning EP. Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis. Arthritis Rheum 1994;37:1521-7.
35. Colao A, Pivonello R, Lastoria S et al. Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease. Eur J Endocrinol 2000;143:S35-S42.